Clinical Research Directory
Browse clinical research sites, groups, and studies.
Brain Activation and Satiety in Children 2
Sponsor: Seattle Children's Hospital
Summary
Childhood obesity and related long-term effects are serious public health problems, but not all children with obesity do well in treatment. This study will test a new combination of family-based behavioral treatment (FBT) with a drug intervention using a glucagon-like peptide-1 receptor agonist (GLP-1RA) exenatide once weekly extended-release (ExQW, Bydureon®) in order to improve obesity intervention outcomes in 10-12-year-old children.
Official title: Brain Systems and Behaviors Underlying Response to Obesity Treatment in Children
Key Details
Gender
All
Age Range
10 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
63
Start Date
2021-01-28
Completion Date
2026-02-12
Last Updated
2026-01-05
Healthy Volunteers
No
Conditions
Interventions
Family Based Behavioral Treatment
Children with obesity accompanied by at least one parent or caregiver will attend 24 weekly sessions. Most sessions will be held via video-conference and include 25-30 min. meetings between an interventionist and each child/parent pair to individualize treatment, followed by separate child and parent group meetings lasting 40 - 45 min. A select few sessions will be held in-person between an interventionist and each child/parent pair with no group session. Parents will serve as primary agents of change for their child and for themselves. Training will focus on food and physical activity education, parenting around food and physical activity, and use of behavioral skills (e.g., self-monitoring, environmental control, contingency management). Intervention groups of 8-12 children/families will be initiated every 3-6 mos. in study yrs. 2-3.
Exenatide 2 mg [Bydureon]
Weekly injections of active drug.
Placebo
Weekly placebo injections
Locations (1)
Seattle Children's Hospital
Seattle, Washington, United States